Galecto (GLTO) News Today $10.65 -7.27 (-40.57%) Closing price 04:00 PM EasternExtended Trading$10.24 -0.41 (-3.85%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Galecto Dropping Today?Toggle Visibility of Why Is Galecto Dropping Today?Galecto, Inc. (NASDAQ: GLTO) shares have exploded higher today on speculative trading around one of the market’s smallest public floats. No new clinical or corporate announcements were released; instead, a massive pre-market buying spree and meme-stock momentum drove volatility, triggering multiple trading halts under the SEC’s LULD mechanism. Positive Sentiment: Galecto stock surged over 600% intraday after a massive pre-market buying spree, climbing from $3.71 to an intraday high near $26.00. Galecto stock skyrockets 600%: why tiny float stocks are market’s latest gamble Positive Sentiment: Shares jumped roughly 575% in regular trading, fueled by speculative momentum around its tiny float. Why Is Galecto Stock (GLTO) Up 575% Today? Neutral Sentiment: Trading was halted multiple times this morning under LULD rules as volatility spiked. Neutral Sentiment: Analysts question whether the roughly 750% rally can be sustained amid no fundamental catalysts. This Penny Stock Just Jumped 750%. Can It Retain These Gains for the Long Term? Negative Sentiment: Retail investors remain cautious, warning the rally lacks new clinical data or corporate news and may reverse sharply. GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious Negative Sentiment: Yesterday’s 2.1% drop and a lack of earnings visibility keep analysts on edge about the stock’s sustainability. Galecto (NASDAQ:GLTO) Shares Down 2.1% – Here's What Happened Posted 1h agoAI Generated. May Contain Errors. GLTO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Galecto stock skyrockets 600%: why tiny float stocks are market’s latest gambleOctober 7 at 11:28 PM | msn.comThis Penny Stock Just Jumped 750%. Can It Retain These Gains for the Long Term?October 7 at 11:28 PM | finance.yahoo.comWhy Is Galecto Stock (GLTO) Up 575% Today?October 7 at 6:28 PM | msn.comGLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain CautiousOctober 7 at 1:27 PM | msn.comGalecto (NASDAQ:GLTO) Shares Down 2.1% - Here's What HappenedOctober 7 at 3:55 AM | americanbankingnews.comGalecto, Inc. Focuses on Oncology and Liver DiseaseAugust 6, 2025 | tipranks.comGalecto Reports Second Quarter 2025 Operating and Financial ResultsAugust 5, 2025 | globenewswire.comGalecto, Inc. (GLTO) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | sg.finance.yahoo.comGalecto, Inc. Reports First Quarter 2025 Financial Results and Progress on AML Treatment DevelopmentMay 10, 2025 | nasdaq.comGalecto, Inc.: Galecto Reports First Quarter 2025 Operating and Financial ResultsMay 9, 2025 | finanznachrichten.deGalecto Reports First Quarter 2025 Operating and Financial ResultsMay 8, 2025 | globenewswire.comGalecto (GLTO)April 12, 2025 | es.investing.comGalecto, Inc. Focuses on Oncology and Liver DiseasesApril 3, 2025 | tipranks.comGalecto trading halted, volatility trading pauseMarch 26, 2025 | markets.businessinsider.comGalecto Reports Full-Year 2024 Financial ResultsMarch 19, 2025 | globenewswire.comGalecto stock hits 52-week low at $4.39 amid market challengesFebruary 12, 2025 | msn.comGalecto to Participate in Upcoming Investor ConferencesFebruary 6, 2025 | globenewswire.comGalecto (NASDAQ:GLTO) Stock, Option ChainNovember 15, 2024 | benzinga.comGalecto, Inc. Announces Strategic Shift and Financial OverviewNovember 2, 2024 | markets.businessinsider.comGalecto, Inc.’s Strategic Shift to Oncology and Liver Diseases: Navigating Risks and OpportunitiesNovember 2, 2024 | tipranks.comGalecto reports Q3 EPS ($3.39) vs ($7.50)November 1, 2024 | msn.comGalecto Reports Third Quarter 2024 Financial ResultsNovember 1, 2024 | globenewswire.comGalecto price target raised to $10 from $9 at OppenheimerOctober 18, 2024 | finance.yahoo.comGalecto incorpora a la Dra. Amy Wechsler a su Consejo de AdministraciónOctober 17, 2024 | es.investing.comOppenheimer Sticks to Its Buy Rating for Galecto (GLTO)October 17, 2024 | markets.businessinsider.comGalecto (NASDAQ:GLTO) Price Target Increased to $10.00 by Analysts at OppenheimerOctober 17, 2024 | marketbeat.comGalecto Strengthens Board of Directors with Appointment of Dr. Amy WechslerOctober 15, 2024 | globenewswire.comGalecto To Focus On Clinical Stage Compound GB1211; Obtains Global Rights To BRM-1420October 7, 2024 | markets.businessinsider.comWhy Galecto (GLTO) Shares Are Down 27% TodayOctober 7, 2024 | msn.comGalecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge MedicinesOctober 7, 2024 | globenewswire.comLas acciones de Galecto tocan un máximo de 52 semanas a 11,67 USD en medio de las fluctuaciones del mercadoAugust 31, 2024 | es.investing.comGalecto Announces Reverse Stock SplitAugust 28, 2024 | globenewswire.comMinerva Neurosciences Inc (4MNA.BE)July 19, 2024 | finance.yahoo.comGLTO Stock Earnings: Galecto Beats EPS for Q1 2024May 3, 2024 | investorplace.comGalecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with PembrolizumabMay 1, 2024 | globenewswire.com6 Stocks Positioned to Soar as Investors Focus on MASHApril 22, 2024 | theglobeandmail.comGLTO Stock Earnings: Galecto Beats EPS for Q4 2023March 15, 2024 | msn.comGalecto Inc.February 16, 2024 | thestreet.comGalecto, Inc. (GLTO) Upgraded to Strong Buy: What Does It Mean for the Stock?February 14, 2024 | finance.yahoo.comWhat Makes Galecto, Inc. (GLTO) a New Strong Buy StockJanuary 9, 2024 | finance.yahoo.comGalecto, Inc.: Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with MyelofibrosisDecember 23, 2023 | finanznachrichten.deNike, AAR And 3 Stocks To Watch Heading Into FridayDecember 22, 2023 | msn.comTopline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with MyelofibrosisDecember 21, 2023 | finance.yahoo.comGalecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 TrialOctober 23, 2023 | finance.yahoo.comGalecto (GLTO) Price Target Increased by 13.16% to 5.48October 5, 2023 | msn.comGalecto, Inc.: Galecto Announces Plans to Explore Strategic AlternativesOctober 1, 2023 | finanznachrichten.deHC Wainwright & Co. Downgrades Galecto (GLTO)September 29, 2023 | msn.comWeeks after dropping lung disease drug, Galecto lays off most of staff, explores saleSeptember 27, 2023 | bizjournals.comGalecto Announces Plans to Explore Strategic AlternativesSeptember 26, 2023 | finance.yahoo.comGalecto Biotech Collapse: Opportunity For Galectin TherapeuticsSeptember 14, 2023 | msn.com Get Galecto News Delivered to You Automatically Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GLTO Media Mentions By Week GLTO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLTO News Sentiment▼0.020.56▲Average Medical News Sentiment GLTO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLTO Articles This Week▼130▲GLTO Articles Average Week Get the Latest News and Ratings for GLTO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Galecto and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ProPhase Labs News Today Lexaria Bioscience News Today Natural Alternatives International News Today Aytu BioPharma News Today Abpro News Today Edesa Biotech News Today Tharimmune News Today Cellectar Biosciences News Today CASI Pharmaceuticals News Today Leap Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLTO) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galecto With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
